Replies to post #145590 on NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

Thanks, this is helpful! I never believed the claim was true but hard to be 100% sure it was completely basis. It's hard to read a lot of slander and not have at least a little bit of doubt rub off on you!

[Rootjim]

Interesting and thanks for your reply. Not being a long term shareholder of NWBO, but will be. Hope others will chime in and all you say is true.IMHO

[chinatown1980]

This is very interesting and I would love to believe you. If what you are saying is true, it makes NWBIO's lack of rebuttal and Woodford's actions even more curious. Why wouldn't they just come right out and dispute the Phase V claims and stabilize the stock? If the claims were so bogus, why was it necessary to form an internal investigative committee? Something is off.

[exwannabe]

(1) there was no big kickback. I know because I purchased a fair amount of those securities and I received delivery. If I got them, Navid didn't (at least my securities).

Thermoo, I certainly have no problem believing the shares were actually sold. That would kind of be the point of it. But why was he even involved with setting up a company to do several "opaque" transactions wrt NWBO?

And it was not just setting it up, Malik's partner had controlling interest for some period of time.

Do you not think they were getting paid for their services? Even if 100% above board, do you not see a conflict of interest between this and his job as an analyst covering the company?

(2) Navid's favorable NW report reflected his true view. He had this view when I met in in London in August/September 2008, way before any supposed kickback.

It is not just that report. How about his public comments during the Swiss Approval story? Anybody even remotely familiar with biotech knew that was a farce. Yet he believed it?

Though the vaccine has only been approved in Switzerland, patients from all over Europe are likely to travel for treatment, Malik said.

Malik upgraded his 2009 sales forecasts to $36 million from $15 million and net income to $11.5 million from $3.3 million.